Zokinvy Interactions
There are 501 drugs known to interact with Zokinvy (lonafarnib), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 263 are major, 223 are moderate, and 15 are minor.
- View all 501 medications that may interact with Zokinvy
- View Zokinvy alcohol/food interactions (1)
- View Zokinvy disease interactions (2)
Most frequently checked interactions
View interaction reports for Zokinvy (lonafarnib) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- ambrisentan
- Amondys 45 (casimersen)
- apremilast
- Aridol (mannitol)
- atoltivimab / maftivimab / odesivimab
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- BabyBIG (botulism immune globulin)
- Bafiertam (monomethyl fumarate)
- baricitinib
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Brevital Sodium (methohexital)
- Breyanzi (lisocabtagene maraleucel)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- butabarbital
- Bylvay (odevixibat)
- Nembutal (pentobarbital)
- Opsumit (macitentan)
Zokinvy alcohol/food interactions
There is 1 alcohol/food interaction with Zokinvy (lonafarnib).
Zokinvy disease interactions
There are 2 disease interactions with Zokinvy (lonafarnib) which include:
More about Zokinvy (lonafarnib)
- Zokinvy consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.